Follow The Filings

TNXP Tonix Pharmaceuticals

Tonix Pharmaceuticals earnings company data as of 4:47 AM ET 10/24

Limited consensus data for this ticker (thin coverage or data-plan limits). Dates may be company-announced rather than sell-side consensus. Calendar and recent prints remain the primary lens when available.

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 9 Nov EPS — — —
Rev — — —

Insider trades

Open-market buys and sales by TNXP's executives, directors and 10% owners in the last 12 months, from their Form 4s

All TNXP insider trades
  • $459K bought by 4 insiders
  • None no sales outside a trading plan
  • None no planned (10b5-1) sales
  1. Seth Lederman CEO
    Buy
    $28K 2,000 shares at $13.79 +22% to stake
    Traded Aug 27 Filed Aug 31
    ↗
  2. Richard H Bagger Director
    Buy
    $13K 1,000 shares at $12.60 New stake
    Traded Aug 20 Filed Aug 24
    ↗
  3. Carolyn E. Taylor Director
    Buy
    $15K 1,415 shares at $10.55 +339% to stake
    Traded Jun 12 Filed Jun 15
    ↗
  4. Seth Lederman CEO
    Buy
    $59K 5,000 shares at $11.79 +125% to stake
    Traded Jun 9 Filed Jun 9
    ↗
  5. Richard Newcomb Stillwell Director
    Buy
    $58K 5,000 shares at $11.65 New stake
    Traded Jun 8 Filed Jun 9
    ↗
  6. Seth Lederman CEO
    Buy
    $63K 5,000 shares at $12.62 +33% to stake
    Traded Mar 31 Filed Apr 1
    ↗
  7. Seth Lederman CEO
    Buy
    $223K 15,000 shares at $14.89 +1500000% to stake
    Traded Mar 18 Filed Mar 18
    ↗

Also filed in the last 12 months, not counted as buying or selling: 1 other transaction.

SEC filings

Recent issuer filings from EDGAR, 25 shown.

Filed Form Detail Links
8-K 2.02,8.01 Filing Doc
8-K 8.01 Filing Doc
8-K 8.01,9.01 Filing Doc
8-K 8.01,9.01 Filing Doc
8-K 5.02,8.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G — Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q QUARTERLY REPORT Filing Doc
8-K 7.01,8.01,9.01 Filing Doc
8-K 5.02 Filing Doc
8-K 7.01,8.01,9.01 Filing Doc
8-K 7.01,8.01,9.01 Filing Doc
SCHEDULE 13G — Filing Doc
8-K 7.01,8.01,9.01 Filing Doc
8-K 7.01,8.01,9.01 Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 7.01,8.01,9.01 Filing Doc
10-Q QUARTERLY REPORT Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 5.02,5.07,9.01 Filing Doc
8-K 7.01,8.01,9.01 Filing Doc
8-K 2.02,8.01 Filing Doc
8-K 7.01,8.01,9.01 Filing Doc

Source: SEC EDGAR submissions, updated 6 days ago. All on EDGAR

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.